Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) was the target of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 3,000,000 shares, a decline of 8.0% from the June 30th total of 3,260,000 shares. Based on an average daily trading volume, of 524,000 […]